Alector Inc (ALEC)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre Partager sur 𝕏

Cours de l'action
Code mnémonique : ALEC Marché : NSM


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette
90 derniers jours
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur totale Détails
2019-12-26 2019-12-24 V Vente

ORBIMED ADVISORS LLC

Large shareholder
15 476 -0.6%
19,59
303 175 USD 		15 476 -0.6% 19,59 303 175 USD
2019-12-26 2019-12-24 V Vente

ORBIMED ADVISORS LLC

Large shareholder
48 324 -0.6%
19,59
946 667 USD 		48 324 -0.6% 19,59 946 667 USD
2019-12-26 2019-12-23 V Vente

ORBIMED ADVISORS LLC

Large shareholder
10 400 -17.4%
19,82
206 128 USD 		10 400 -17.4% 19,82 206 128 USD
2019-12-26 2019-12-23 V Vente

ORBIMED ADVISORS LLC

Large shareholder
20 350 -0.8%
19,82
403 337 USD 		20 350 -0.8% 19,82 403 337 USD
2019-12-26 2019-12-23 V Vente

ORBIMED ADVISORS LLC

Large shareholder
63 535 -0.8%
19,82
1 259 264 USD 		63 535 -0.8% 19,82 1 259 264 USD
2019-12-26 2019-12-20 V Vente

ORBIMED ADVISORS LLC

Large shareholder
37 900 -38.8%
19,66
745 114 USD 		37 900 -38.8% 19,66 745 114 USD
2019-12-26 2019-12-20 V Vente

ORBIMED ADVISORS LLC

Large shareholder
73 879 -2.7%
19,66
1 452 461 USD 		73 879 -2.7% 19,66 1 452 461 USD
2019-12-26 2019-12-20 V Vente

ORBIMED ADVISORS LLC

Large shareholder
230 721 -2.7%
19,66
4 535 975 USD 		230 721 -2.7% 19,66 4 535 975 USD
2019-12-19 2019-12-17 V Vente

ORBIMED ADVISORS LLC

Large shareholder
105 500 -51.9%
18,52
1 953 860 USD 		105 500 -51.9% 18,52 1 953 860 USD
2019-12-19 2019-12-17 V Vente

ORBIMED ADVISORS LLC

Large shareholder
205 793 -6.9%
18,52
3 811 286 USD 		205 793 -6.9% 18,52 3 811 286 USD
2019-12-19 2019-12-17 V Vente

ORBIMED ADVISORS LLC

Large shareholder
642 807 -6.9%
18,52
11 904 786 USD 		642 807 -6.9% 18,52 11 904 786 USD
2019-12-17 2019-12-13 VP Vente planifiée

Paul Robert

Chief Medical Officer

Dirigeant
10 000 -3.4%
20,03
200 300 USD 		10 000 -3.4% 20,03 200 300 USD
2019-12-16 2019-12-12 VP Vente planifiée

Oney Sabah

Chief Business Officer

Dirigeant
6 810 -1.1%
20,13
137 069 USD 		6 810 -1.1% 20,13 137 069 USD
2019-12-12 2019-12-10 VP Vente planifiée

Oney Sabah

Chief Business Officer

Dirigeant
500 -0.1%
20,01
10 005 USD 		500 -0.1% 20,01 10 005 USD
2019-12-09 2019-12-09 VP Vente planifiée

Oney Sabah

Chief Business Officer

Dirigeant
2 300 -0.4%
20,07
46 161 USD 		2 300 -0.4% 20,07 46 161 USD
2019-12-09 2019-12-06 VP Vente planifiée

Oney Sabah

Chief Business Officer

Dirigeant
5 156 -0.9%
20,02
103 223 USD 		5 156 -0.9% 20,02 103 223 USD
2019-12-09 2019-12-05 VP Vente planifiée

Oney Sabah

Chief Business Officer

Dirigeant
1 500 -0.3%
20,00
30 000 USD 		1 500 -0.3% 20,00 30 000 USD
2019-12-05 2019-12-03 VP Vente planifiée

Yu Calvin

Vice President, Finance

Dirigeant
1 315 -0.7%
18,31
24 078 USD 		1 315 -0.7% 18,31 24 078 USD
2019-11-19 2019-11-15 VP Vente planifiée

Paul Robert

Chief Medical Officer

Dirigeant
10 000 -3.3%
15,93
159 300 USD 		10 000 -3.3% 15,93 159 300 USD
2019-11-19 2019-11-15 VP Vente planifiée

King Robert

Chief Development Officer

Dirigeant
7 500 -1.4%
15,92
119 400 USD 		7 500 -1.4% 15,92 119 400 USD
2019-10-17 2019-10-15 VP Vente planifiée

Paul Robert

Chief Medical Officer
10 000 -3.2%
14,68
146 800 USD 		10 000 -3.2% 14,68 146 800 USD
2019-09-24 2019-09-20 VP Vente planifiée

Oney Sabah

Chief Business Officer
400 -0.1%
20,00
8 000 USD 		400 -0.1% 20,00 8 000 USD
2019-09-24 2019-09-20 VP Vente planifiée

Paul Robert

Chief Medical Officer
4 000 -1.3%
20,00
80 000 USD 		4 000 -1.3% 20,00 80 000 USD
2019-09-18 2019-09-16 VP Vente planifiée

Paul Robert

Chief Medical Officer
10 000 -3.1%
19,08
190 800 USD 		10 000 -3.1% 19,08 190 800 USD
2019-08-21 2019-08-20 VP Vente planifiée

Paul Robert

Chief Medical Officer

Dirigeant
916 -0.3%
16,00
14 656 USD 		916 -0.3% 16,00 14 656 USD
2019-08-21 2019-08-19 VP Vente planifiée

Paul Robert

Chief Medical Officer

Dirigeant
1 084 -0.3%
16,00
17 344 USD 		1 084 -0.3% 16,00 17 344 USD
2019-08-21 2019-08-19 VP Vente planifiée

King Robert

Chief Development Officer

Dirigeant
7 500 -1.4%
15,00
112 500 USD 		7 500 -1.4% 15,00 112 500 USD
2019-08-19 2019-08-15 VP Vente planifiée

Paul Robert

Chief Medical Officer

Dirigeant
10 000 -3.0%
14,19
141 900 USD 		10 000 -3.0% 14,19 141 900 USD
2019-08-09 2019-08-07 V Vente

ORBIMED ADVISORS LLC

Large shareholder
157 636 -5.0%
17,90
2 821 684 USD 		157 636 -5.0% 17,90 2 821 684 USD
2019-08-09 2019-08-07 V Vente

ORBIMED ADVISORS LLC

Large shareholder
492 364 -5.0%
17,90
8 813 316 USD 		492 364 -5.0% 17,90 8 813 316 USD
2019-02-11 2019-02-11 A Achat

GORDON CARL L

Administrateur non-exécutif Large shareholder
203 200 +inf%
19,00
3 860 800 USD 		203 200 +inf% 19,00 3 860 800 USD
2019-02-11 2019-02-11 A Achat

GORDON CARL L

Administrateur non-exécutif Large shareholder
50 561 +2.1%
19,00
960 659 USD 		50 561 +2.1% 19,00 960 659 USD
2019-02-11 2019-02-11 A Achat

GORDON CARL L

Administrateur non-exécutif Large shareholder
157 939 +1.5%
19,00
3 000 841 USD 		157 939 +1.5% 19,00 3 000 841 USD
2019-02-11 2019-02-11 A Achat

ORBIMED ADVISORS LLC

Administrateur non-exécutif Large shareholder
203 200 +inf%
19,00
3 860 800 USD 		203 200 +inf% 19,00 3 860 800 USD
2019-02-11 2019-02-11 A Achat

ORBIMED ADVISORS LLC

Administrateur non-exécutif Large shareholder
50 561 +2.1%
19,00
960 659 USD 		50 561 +2.1% 19,00 960 659 USD
2019-02-11 2019-02-11 A Achat

ORBIMED ADVISORS LLC

Administrateur non-exécutif Large shareholder
157 939 +1.5%
19,00
3 000 841 USD 		157 939 +1.5% 19,00 3 000 841 USD